Stock listing

Twist Bioscience Corporation

Selected listing: 0ME · GETTEX · EUR · DE

Twist Bioscience Corporation (gettex:0ME), Health Technology. Latest release Sep 16, 2026: Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug…

0ME:GETTEXEURDEUpdated October 2, 2026

Ticker: gettex:0ME
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: gettex
Currency: EUR

About Twist Bioscience Corporation

The company specializes in synthetic biology and DNA synthesis, providing innovative solutions for various applications in healthcare, agriculture, and industrial biotechnology. Twist Bioscience aims to advance the field of genomics through its cutting-edge technology and services.

Latest news from Twist Bioscience Corporation

Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery

September 16, 2026

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(4)

August 5, 2026

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

August 4, 2026

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

August 3, 2026

Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026

July 15, 2026

All Twist Bioscience Corporation news →

Events

Replays

Twist Bioscience Corporation (TWST) Q3 2026 Earnings Call
Mon, Aug 03, 2026 · 08:00 AM ET
Watch
Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call
Mon, May 04, 2026 · 08:00 AM ET
Watch
Twist Bioscience Corporation (TWST) Q1 2026 Earnings Call
Mon, Feb 02, 2026 · 08:00 AM ET
Watch

Research Twist Bioscience Corporation

Twist Bioscience Corporation company profile

View the public company page for Twist Bioscience Corporation on 6ix.

Twist Bioscience Corporation news

Read company news and market updates connected to Twist Bioscience Corporation.

Twist Bioscience Corporation investor events

Find investor webinars, events, and replay context for Twist Bioscience Corporation.